SCHEMBL7707699

SCHEMBL7707699

O=C(CO)NCCCCCCNC(=O)CO

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
SMN1; SMN2 Q16637 2/20 0.62
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
NAAA Q02083 1/20 0.52
CASP2 P42575 1/20 0.50
KDM4E B2RXH2 1/20 0.50
MAPK1 P28482 1/20 0.50
HIF1A Q16665 1/20 0.50
EPHX1 P07099 5/20 0.44
ALDH1A2 O94788 1/20 0.44
ALDH2 P05091 1/20 0.44
ALDH1A3 P47895 1/20 0.44
PRMT1 Q99873 1/20 0.42
FAAH O00519 1/20 0.42
PAOX Q6QHF9 2/20 0.41
POLB P06746 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8746936 1.00 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2ANAAA
SCHEMBL1156355 1.00 ALDH1A1 (0.62) ALDH1A1SMN1; SMN2MEN1KMT2ANAAA
SCHEMBL19607964 0.92 ALDH1A1 (0.54) ALDH1A1SMN1; SMN2MEN1KMT2ANAAA
SCHEMBL5143910 0.89 MEN1 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2ANAAA
SCHEMBL23168896 0.88 MEN1 (0.50) ALDH1A1SMN1; SMN2MEN1KMT2ANAAA
SCHEMBL8046166 0.88 NAAA (0.70) MEN1KMT2ANAAACASP2EPHX1
SCHEMBL10357569 0.88 NAAA (0.70) MEN1KMT2ANAAACASP2EPHX1
SCHEMBL20472580 0.88 NAAA (0.70) MEN1KMT2ANAAACASP2EPHX1
SCHEMBL20472253 0.88 NAAA (0.70) MEN1KMT2ANAAACASP2EPHX1
SCHEMBL8879613 0.88 NAAA (0.70) MEN1KMT2ANAAACASP2EPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365172-B1 SELF-REINFORCED BIOABSORBABLE DEVICE COMPRISED OF FUSED OR SINTERED FIBERS MADE FROM BIOABSORBABLE POLYMER COMPRISING SPECIFIED POLYESTERAMIDE BIOAMIDE, INC. 2002-04-02 US claimed
US-6120788-A Bioabsorbable triglycolic acid poly(ester-amide)s BIOAMIDE, INC. (US) 2000-09-19 US claimed
US-20130035402-A1 BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF BEZWADA BIOMEDICAL, LLC (US) 2013-02-07 US disclosed
US-8309132-B2 Bioabsorbable polyesteramides and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2012-11-13 US disclosed
US-8309132-B2 Bioabsorbable polyesteramides and uses thereof BEZWADA BIOMEDICAL, LLC (US) 2012-11-13 US disclosed
US-20090285896-A1 BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF BEZWADA BIOMEDICAL, LLC (US) 2009-11-19 US disclosed
US-20090285896-A1 BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF BEZWADA BIOMEDICAL, LLC (US) 2009-11-19 US disclosed
US-6365172-B1 SELF-REINFORCED BIOABSORBABLE DEVICE COMPRISED OF FUSED OR SINTERED FIBERS MADE FROM BIOABSORBABLE POLYMER COMPRISING SPECIFIED POLYESTERAMIDE BIOAMIDE, INC. 2002-04-02 US disclosed
US-6120788-A Bioabsorbable triglycolic acid poly(ester-amide)s BIOAMIDE, INC. (US) 2000-09-19 US disclosed
EP-0621881-B1 PROCESS FOR INCREASING STABILITY OF POLY(ESTERAMIDES) MINNESOTA MINING & MFG (US) 1997-03-05 EP disclosed
EP-0621881-A1 PROCESS FOR INCREASING STABILITY OF POLY(ESTERAMIDES). MINNESOTA MINING & MFG (US) 1994-11-02 EP disclosed
US-5286837-A Suspending in an amide solvent MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-02-15 US disclosed
WO-1993015130-A2 PROCESS FOR INCREASING STABILITY OF POLY(ESTERAMIDES) MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1993-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090285896-A1 BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF PAICS, UROD, PUF60 ALDH1A1 3434/4885SMN1; SMN2 1627/4885MEN1 162/4885
US-20130035402-A1 BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF PAICS, UROD, PUF60 ALDH1A1 3434/4885SMN1; SMN2 1627/4885MEN1 162/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.